02605nas 2200577- 450 99621370420331620240119213020.02198-6584(DE-599)ZDB2783278-8(OCoLC)890026801(CKB)3710000000219340(CONSER)--2016243015(NjHacI)993710000000219340(EXLCZ)99371000000021934020140901a20149999 o-- -engur|||||||||||txtrdacontentcrdamediacrrdacarrierRheumatology and therapy[London] :Springer Healthcare,[2014]-1 online resourceRefereed/Peer-reviewed2198-6576 Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.RHEUMATOL THERRheumatol. ther.Rheumatologyfast(OCoLC)fst01097048Physical and Rehabilitation MedicineRheumatologyRheumatic DiseasesRheumatismPhysical therapyPeriodicalsRheumatologyPeriodicalsPeriodical.Periodicals.fastRheumatology.Physical and Rehabilitation Medicine.Rheumatology.Rheumatic Diseases.RheumatismPhysical therapyRheumatology616.7444.83bclNjHacINjHaclJOURNAL996213704203316Rheumatology and therapy2146629UNISA